Corbus Pharmaceuticals Holding (CRBP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $69.86M
Last updated: Nov 17, 2026 at 11:04 AM ET
Corbus Pharmaceuticals Holding (CRBP) Earnings: Report Dates and Results
Corbus Pharmaceuticals Holding (CRBP) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Corbus Pharmaceuticals Holding reported EPS of -$1.81, below the -$1.45 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CRBP has an expected report date of Mar 8, 2027.
Earnings History
Of the 40 quarters below that had an estimate, CRBP beat 16, missed 23 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.08M, down 4.4% from $1.13M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$1.81 | -$1.45 | -$1.91 - -$0.73 | -24.83% | Miss | N/A | 10 | 0 up, 1 down | Nov 10, 2026 | $1.08M |
| Jun 30, 2026 | -$1.81 | -$1.30 | -$1.38 - -$1.15 | -39.23% | Miss | N/A | 10 | 0 up, 3 down | Aug 6, 2026 | $1.16M |
| Mar 31, 2026 | -$1.23 | -$1.22 | -$1.37 - -$1.02 | -0.82% | Miss | N/A | 8 | 3 up, 2 down | May 12, 2026 | $1.40M |
| Dec 31, 2025 | -$1.25 | -$1.58 | -$3.57 - -$0.94 | +20.69% | Beat | N/A | 10 | 4 up, 5 down | Mar 9, 2026 | $1.41M |
| Sep 30, 2025 | -$1.90 | -$1.71 | -$3.27 - -$1.43 | -11.11% | Miss | N/A | 10 | 2 up, 6 down | Nov 12, 2025 | $1.13M |
| Jun 30, 2025 | -$1.44 | -$1.33 | -$1.65 - -$0.86 | -8.27% | Miss | N/A | 9 | 2 up, 4 down | Aug 5, 2025 | $1.31M |
| Mar 31, 2025 | -$1.39 | -$1.07 | -$1.30 - -$0.87 | -29.91% | Miss | N/A | 7 | 3 up, 0 down | May 6, 2025 | $1.68M |
| Dec 31, 2024 | -$0.78 | -$1.26 | -$1.52 - -$1.02 | +38.04% | Beat | N/A | 9 | 0 up, 1 down | Mar 11, 2025 | $4.71M |
| Sep 30, 2024 | -$1.15 | -$0.95 | -$1.14 - -$0.74 | -21.05% | Miss | N/A | 8 | 0 up, 0 down | Nov 7, 2024 | N/A |
| Jun 30, 2024 | -$0.90 | -$1.19 | -$1.71 - -$0.80 | +24.37% | Beat | N/A | 6 | 0 up, 0 down | Aug 6, 2024 | $1.60M |
| Mar 31, 2024 | -$0.83 | -$1.09 | -$1.22 - -$0.96 | +23.85% | Beat | N/A | 2 | 0 up, 0 down | May 7, 2024 | N/A |
| Dec 31, 2023 | -$1.81 | -$2.36 | -$2.50 - -$2.22 | +23.31% | Beat | N/A | 2 | 0 up, 0 down | Mar 12, 2024 | $1.64M |
| Sep 30, 2023 | -$2.27 | -$2.06 | -$2.06 - -$2.06 | -10.19% | Miss | N/A | 1 | 0 up, 0 down | Nov 7, 2023 | N/A |
| Jun 30, 2023 | -$2.05 | -$3.10 | -$3.10 - -$3.10 | +33.87% | Beat | N/A | 1 | 0 up, 0 down | Aug 8, 2023 | N/A |
| Mar 31, 2023 | -$4.24 | -$4.09 | -$4.09 - -$4.09 | -3.67% | Miss | N/A | 1 | 0 up, 0 down | May 9, 2023 | N/A |
| Dec 31, 2022 | -$2.61 | -$2.10 | -$2.40 - -$1.80 | -24.29% | Miss | N/A | 3 | 0 up, 0 down | Mar 7, 2023 | N/A |
| Sep 30, 2022 | -$2.10 | -$1.65 | -$2.10 - -$1.20 | -27.27% | Miss | N/A | 2 | 0 up, 0 down | Nov 8, 2022 | N/A |
| Jun 30, 2022 | -$3.30 | -$1.80 | -$2.10 - -$1.50 | -83.33% | Miss | N/A | 2 | 0 up, 0 down | Aug 9, 2022 | N/A |
| Mar 31, 2022 | -$2.40 | -$2.55 | -$3.30 - -$1.80 | +5.88% | Beat | N/A | 2 | 0 up, 0 down | May 10, 2022 | N/A |
| Dec 31, 2021 | -$2.40 | -$3.22 | -$3.60 - -$3.00 | +25.47% | Beat | N/A | 4 | N/A | Mar 8, 2022 | N/A |
| Sep 30, 2021 | -$0.60 | -$3.30 | -$3.90 - -$2.70 | +81.82% | Beat | N/A | 4 | N/A | Nov 12, 2021 | $97323 |
| Jun 30, 2021 | -$4.50 | -$3.75 | -$3.90 - -$2.70 | -20.00% | Miss | N/A | 5 | N/A | Aug 12, 2021 | $136558 |
| Mar 31, 2021 | -$4.20 | -$4.80 | -$5.71 - -$3.30 | +12.50% | Beat | N/A | 5 | N/A | May 13, 2021 | $647824 |
| Dec 31, 2020 | -$3.00 | -$7.56 | -$11.71 - -$4.50 | +60.32% | Beat | N/A | 5 | N/A | Mar 15, 2021 | $658204 |
| Sep 30, 2020 | -$12.90 | -$12.18 | -$15.62 - -$9.91 | -5.91% | Miss | N/A | 7 | N/A | Nov 10, 2020 | $1.23M |
| Jun 30, 2020 | -$15.60 | -$11.25 | -$13.81 - -$9.61 | -38.67% | Miss | -1833.3% | 7 | N/A | Aug 6, 2020 | $286346 |
| Mar 31, 2020 | -$12.90 | -$12.70 | -$15.32 - -$9.31 | -1.57% | Miss | N/A | 6 | N/A | May 11, 2020 | $1.76M |
| Dec 31, 2019 | -$12.30 | -$10.74 | -$12.01 - -$6.91 | -14.53% | Miss | N/A | 5 | N/A | Mar 12, 2020 | $2.57M |
| Sep 30, 2019 | -$9.60 | -$10.90 | -$12.91 - -$9.61 | +11.93% | Beat | N/A | 5 | N/A | Nov 7, 2019 | $2.59M |
| Jun 30, 2019 | $0.90 | -$10.68 | -$13.21 - -$9.31 | +108.43% | Beat | N/A | 5 | N/A | Aug 8, 2019 | $29.09M |
| Mar 31, 2019 | -$12.90 | -$4.45 | N/A | -189.89% | Miss | N/A | 5 | N/A | May 9, 2019 | $1.89M |
| Dec 31, 2018 | -$9.00 | -$7.80 | -$8.71 - -$6.61 | -15.38% | Miss | N/A | 6 | N/A | Mar 12, 2019 | $1.93M |
| Sep 30, 2018 | -$7.80 | -$6.65 | -$7.51 - -$6.01 | -17.29% | Miss | N/A | 6 | N/A | Nov 8, 2018 | $1.09M |
| Jun 30, 2018 | -$6.30 | -$6.45 | -$6.91 - -$6.01 | +2.33% | Beat | N/A | 4 | N/A | Aug 8, 2018 | $853646 |
| Mar 31, 2018 | -$6.30 | -$4.10 | -$6.31 - -$2.40 | -53.66% | Miss | N/A | 3 | N/A | May 10, 2018 | $950442 |
| Dec 31, 2017 | -$6.30 | -$4.62 | -$5.11 - -$4.20 | -36.36% | Miss | N/A | 5 | N/A | Mar 12, 2018 | N/A |
| Sep 30, 2017 | -$4.20 | -$4.80 | -$5.11 - -$4.50 | +12.50% | Beat | N/A | 3 | N/A | Nov 8, 2017 | $796312 |
| Jun 30, 2017 | -$4.50 | -$5.60 | -$6.01 - -$5.11 | +19.64% | Beat | N/A | 3 | N/A | Aug 9, 2017 | $350186 |
| Mar 31, 2017 | -$4.80 | -$4.80 | N/A | 0.00% | In line | N/A | N/A | N/A | May 9, 2017 | $1.29M |
| Dec 31, 2016 | -$5.40 | -$4.10 | N/A | -31.71% | Miss | N/A | N/A | N/A | Mar 9, 2017 | $375670 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$5.98, after -$3.66 the year before. It was -$14.70 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$5.98 | N/A |
| Dec 31, 2024 | -$3.66 | N/A |
| Dec 31, 2023 | -$10.37 | N/A |
| Dec 31, 2022 | -$10.41 | N/A |
| Dec 31, 2021 | -$11.70 | N/A |
| Dec 31, 2020 | -$44.40 | N/A |
| Dec 31, 2019 | -$33.90 | N/A |
| Dec 31, 2018 | -$29.40 | N/A |
| Dec 31, 2017 | -$19.80 | N/A |
| Dec 31, 2016 | -$14.70 | N/A |
Frequently Asked Questions About CRBP
When is Corbus Pharmaceuticals Holding's next earnings date?
Corbus Pharmaceuticals Holding's next earnings report is expected for Mar 8, 2027.
Did CRBP beat earnings estimates last quarter?
No. Corbus Pharmaceuticals Holding reported EPS of -$1.81 for the quarter ended Sep 30, 2026, below the -$1.45 estimate by 24.83%.
What EPS do analysts expect from CRBP next quarter?
The consensus EPS estimate for Corbus Pharmaceuticals Holding for the quarter ending Dec 31, 2026 is -$1.42 from 12 analysts, with estimates from -$1.96 to -$0.78.
How often does CRBP beat earnings estimates?
Corbus Pharmaceuticals Holding beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -6.93%.
CRBP pages: Overview, Earnings, Forecast, Financials, Competitors